Menu
Virtual Visit Request an Appointment ER Wait Times
Search
Back

Filter By

All Search Results

  • Samantha Spishock, PharmD

    Samantha Spishock, PharmD, is a clinical pharmacist specializing in pediatric hematology/oncology at Arnold Palmer Hospital for Children. She received her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy at University of the Sciences in Philadelphia, PA. She then completed a postgraduate pharmacy practice residency at Lehigh Valley Health Network in Allentown, PA followed by a pediatric pharmacy residency at Rutgers University Ernest Mario School of Pharmacy in Piscataway, NJ.

  • Stefano Cardin, MD

    Dr. Stefano Cardin is a fellowship-trained pediatric orthopedic surgeon at Orlando Health Arnold Palmer Hospital for Children Center for Orthopedics. His specialties include:

  • Lisa K. Christensen, MD

    Lisa Christensen, MD

  • Mario Enrique Zelaya, MD

    Mario Zelaya, MD

  • Marnie B. Robinson, MD

    Marnie Robinson, MD

  • Michael F. Marzouk, MD

    Michael Marzouk, MD, is the division chief of pediatric anesthesia for Orlando Health, and a member of Orlando Health Pediatric Anesthesia Consultants, where he provides anesthesia for patients at Orlando Health Arnold Palmer Hospital for Children. He is board certified in anesthesiology and pediatric anesthesiology.

  • Jose A. Decamps Solano, MD

    Dr. Jose Decamps is a board-certified pediatric cardiologist with the Orlando Health Children's Heart Institute. His specialties include:

  • Julia Young, LMHC

    Julia Young is a licensed mental health counselor and certified child life specialist with Orlando Health Arnold Palmer Hospital for Children Pediatric Palliative Care. As a palliative care counselor, she helps children and their families navigate through their medical journey. That often includes:

  • A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

    A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma and Reduced Therapy in Children With Medulloblastoma With Low-Risk Features

  • Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)

    Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma